Summary of search strategy for eligible Epidermolysis bullosa acquisita cases

Published: 4 December 2025| Version 1 | DOI: 10.17632/p3y84zcnhx.1
Contributor:
Gaurav Pathak

Description

This is a supplemental PRISMA style figure detailing the selection criteria for eligible drug and vaccine associated EBA patients.

Files

Categories

Adverse Effect of Drug, Epidermolysis bullosa, Blistering

Licence